Neurothera Labs Inc. (TSXV:NTLX)

Canada flag Canada · Delayed Price · Currency is CAD
0.155
0.00 (0.00%)
Mar 6, 2026, 9:30 AM EST
3.33%
Market Cap 13.16M
Revenue n/a
Net Income n/a
Shares Out 84.90M
EPS n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 8,882
Open 0.155
Previous Close 0.155
Day's Range 0.155 - 0.155
52-Week Range 0.155 - 0.260
Beta -0.08
RSI 46.51
Earnings Date n/a

About Neurothera Labs

Neurothera Labs Inc. operates a clinical-stage pharmaceutical company. The company engages in the drug development programs based on THC and/or non-psychoactive CBD: SCI-110 for the treatment of Tourette syndrome, for the treatment of Alzheimer's disease and agitation; and SCI- 210 for the treatment of ASD and status epilepticus. Neurothera Labs Inc. was formerly known as Miza III Ventures Inc. The company is based in Vancouver, Canada. As of February 23, 2023, Neurothera Labs Inc. operates as a subsidiary of SciSparc Ltd. [Read more]

Industry Shell Companies
Sector Financials
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol NTLX
Full Company Profile

News

There is no news available yet.